Search

Your search keyword '"Dason, Shawn"' showing total 243 results
Start Over Author "Dason, Shawn"
243 results on '"Dason, Shawn"'

3. Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

Author

Lenis, Andrew T., Whiting, Karissa, Ravichandran, Vignesh, Tallman, Jacob E., Alam, Syed M., Chu, Carissa E., Jesus Escano, Manual De, Bochner, Emily, Katims, Andrew, Reisz, Peter A., Truong, Hong, Clinton, Timothy N., Telis, Leon, Dason, Shawn, McPherson, Victor, Teo, Min Yuen, Funt, Samuel, Aggen, David, Goh, Alvin C., Donahue, Timothy F., Cha, Eugene K., Donat, S. Machele, Herr, Harry W., Dalbagni, Guido, Schultz, Nikolaus, Berger, Michael F., Bajorin, Dean F., Rosenberg, Jonathan E., Bochner, Bernard H., Ostrovnaya, Irina, Al-Ahmadie, Hikmat, Solit, David B., Iyer, Gopa, and Pietzak, Eugene J.

Published
2024
Full Text
View/download PDF

4. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement

Author

Deivasigamani, Sriram, Kotamarti, Srinath, Rastinehad, Ardeshir R., Salas, Rafael Sanchez, de la Rosette, J.J.M.C.H., Lepor, Herbert, Pinto, Peter, Ahmed, Hashim U., Gill, Inderbir, Klotz, Laurence, Taneja, Samir S., Emberton, Mark, Lawrentschuk, Nathan, Wysock, James, Feller, John F., Crouzet, Sebastien, Kumar M., Praveen, Seguier, Denis, Adams, Eric S., Michael, Zoe, Abreu, Andre, Jack Tay, Kae, Ward, John F., Shinohara, Katsuto, Katz, Aaron E., Villers, Arnauld, Chin, Joseph L., Stricker, Phillip D., Baco, Eduard, Macek, Petr, Ahmad, Ardalan E., Chiu, Peter K.F., Crawford, E. David, Rogers, Craig G., Futterer, Jurgen J., Rais-Bahrami, Soroush, Robertson, Cary N., Hadaschik, Boris, Marra, Giancarlo, Valerio, Massimo, Chong, Kian Tai, Kasivisvanathan, Veeru, Tan, Wei Phin, Lomas, Derek, Walz, Jochen, Guimaraes, Gustavo Cardoso, Mertziotis, Nikos I., Becher, Ezequiel, Finelli, Antonio, Kasraeian, Ali, Lebastchi, Amir H., Vora, Anup, Rosen, Mark A., Bakir, Baris, Arcot, Rohit, Yee, Samuel, Netsch, Christopher, Meng, Xiaosong, de Reijke, Theo M., Tan, Yu Guang, Regusci, Stefano, Benjamin, Tavya G.R., Olivares, Ruben, Noureldin, Mohamed, Bianco, Fernando J., Sivaraman, Arjun, Kim, Fernando J., Given, Robert W., Dason, Shawn, Sheetz, Tyler J., Shoji, Sunao, Schulman, Ariel, Royce, Peter, Shah, Taimur T., Scionti, Stephen, Salomon, Georg, Laguna, Pilar, Tourinho-Barbosa, Rafael, Aminsharifi, Alireza, Cathelineau, Xavier, Gontero, Paolo, Stabile, Armando, Grummet, Jeremy, Ledbetter, Leila, Graton, Margaret, Stephen Jones, J., and Polascik, Thomas J.

Published
2023
Full Text
View/download PDF

8. Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research

Author

Elbialy, Abdalla, primary, Kappala, Deepthi, additional, Desai, Dhruv, additional, Wang, Peng, additional, Fadiel, Ahmed, additional, Wang, Shang-Jui, additional, Makary, Mina S., additional, Lenobel, Scott, additional, Sood, Akshay, additional, Gong, Michael, additional, Dason, Shawn, additional, Shabsigh, Ahmad, additional, Clinton, Steven, additional, Parwani, Anil V., additional, Putluri, Nagireddy, additional, Shvets, Gennady, additional, Li, Jenny, additional, and Liu, Xuefeng, additional

Published
2024
Full Text
View/download PDF

10. Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening.

Author

Sheetz, Tyler, Posid, Tasha, Khuhro, Aliza, Scimeca, Alicia, Beebe, Sarah, Gul, Essa, and Dason, Shawn

Subjects
MEDICAL screening, COMMON misconceptions, EARLY detection of cancer, PROSTATE cancer, PROSTATE-specific antigen
Abstract

Introduction: Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics. Methods: A survey was completed by 906 male-identifying participants (age > 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45). Results: The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier (p < 0.001). A number of misconceptions were evident in the responses. Conclusions: Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Urology

Author

Dason, Shawn, Lee, Cheryl T., Shabsigh, Ahmad, Todd, Knox H., editor, Thomas, Jr., Charles R., editor, and Alagappan, Kumar, editor

Published
2021
Full Text
View/download PDF

18. Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma

Author

Kwok, Christopher, primary, Khorasanchi, Adam, additional, Psutka, Sarah P., additional, Hinkley, Megan, additional, Dason, Shawn, additional, Sundi, Debasish, additional, Yang, Yuanquan, additional, Yang, Yajing, additional, Verschraegen, Claire, additional, Gross, Evan E., additional, Orcutt, Delaney, additional, and Yin, Ming, additional

Published
2023
Full Text
View/download PDF

20. Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma.

Author

Raj, Rohit K., Upadhyay, Rituraj, Wang, Shang-Jui, Singer, Eric A., and Dason, Shawn

Subjects
STEREOTACTIC radiotherapy, VENA cava inferior, STEREOTACTIC radiosurgery, KIDNEY tumors, ELECTRONIC information resource searching
Abstract

Stereotactic ablative radiotherapy (SABR) has challenged the conventional wisdom surrounding the radioresistance of renal cell carcinoma (RCC). In the past decade, there has been a significant accumulation of clinical data to support the safety and efficacy of SABR in RCC. Herein, we review the use of SABR across the spectrum of RCC. We performed an online search of the Pubmed database from January 1990 through April 2023. Studies of SABR/stereotactic radiosurgery targeting primary, extracranial, and intracranial metastatic RCC were included. For SABR in non-metastatic RCC, this includes its use in small renal masses, larger renal masses, and inferior vena cava tumor thrombi. In the metastatic setting, SABR can be used at diagnosis, for oligometastatic and oligoprogressive disease, and for symptomatic reasons. Notably, SABR can be used for both the primary renal tumor and metastasis-directed therapy. Management of RCC is evolving rapidly, and the role that SABR will have in this landscape is being assessed in a number of ongoing prospective clinical trials. The objective of this narrative review is to summarize the evidence corroborating the use of SABR in RCC. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

21. PD24-02 IMPACT OF SYSTEMIC THERAPY (ST) ON DEFERRED CYTOREDUCTIVE NEPHRECTOMY (CN) PERIOPERATIVE OUTCOMES: A NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) ANALYSIS

Author

Dason, Shawn, primary, Sheetz, Tyler, additional, Ray, Shagnik, additional, Zimmerman, Danielle, additional, Yin, Ming, additional, Folefac, Edmund, additional, Mortazavi, Amir, additional, Gong, Michael, additional, Shabsigh, Ahmad, additional, Posid, Tasha, additional, and Singer, Eric, additional

Published
2023
Full Text
View/download PDF

25. Intraoperative Embolization during Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma.

Author

Roberts, Samantha A., Satija, Divyaam, Gold, Henry, Makary, Mina S., Wang, Jing G., Singer, Eric A., Posid, Tasha, Mokadam, Nahush A., and Dason, Shawn

Subjects
VENA cava inferior, KIDNEY tumors, RIGHT heart atrium, ENDOVASCULAR surgery, OPERATIVE surgery, ANGIOMYOLIPOMA, RENAL cell carcinoma
Abstract

Intraoperative tumor thrombus embolization is a potentially lethal complication during inferior vena cava (IVC) thrombectomy for renal cell carcinoma (RCC). Intraoperative embolization is uncommonly encountered because IVC thrombectomy surgical technique is focused on avoiding this complication. Nonetheless, early recognition of embolization is essential so that emergent management can be instituted. When available, cardiopulmonary bypass (CPB) and embolectomy should be considered the gold standard for the management of intraoperative embolization. Several novel endovascular techniques are also available for selective use. We present the case of a 71-year-old female with a right renal mass and level II (retrohepatic) IVC tumor thrombus. During cytoreductive nephrectomy and IVC thrombectomy, tumor embolization was diagnosed during a period of hypotension based on transesophageal echocardiographic finding of new thrombus within the right atrium. This prompted sternotomy, CPB, and pulmonary artery embolectomy. The patient survived this embolization event and has a complete response to systemic therapy 9 months postoperatively. This case serves as the framework for a discussion on management considerations surrounding intraoperative embolization during IVC thrombectomy. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

26. Impact of systemic therapy (ST) on deferred cytoreductive nephrectomy (CN) perioperative outcomes: A National Surgical Quality Improvement Program (NSQIP) analysis.

Author

Dason, Shawn, primary, Sheetz, Tyler, additional, Ray, Shagnik, additional, Zimmerman, Danielle Elise, additional, Yin, Ming, additional, Folefac, Edmund, additional, Mortazavi, Amir, additional, Gong, Michael, additional, Shabsigh, Ahmad, additional, and Singer, Eric A., additional

Published
2023
Full Text
View/download PDF

28. Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Author

Clinton, Timothy N., primary, Chen, Ziyu, additional, Wise, Hannah, additional, Lenis, Andrew T., additional, Chavan, Shweta, additional, Donoghue, Mark T.A., additional, Almassi, Nima, additional, Chu, Carissa E., additional, Dason, Shawn, additional, Rao, Pavitra, additional, Rodrigues, James A., additional, Vasani, Naresh B., additional, Ridouani, Fourat, additional, Rosenberg, Jonathan E., additional, Bajorin, Dean F., additional, Teo, Min Yuen, additional, Bochner, Bernard H., additional, Berger, Michael F., additional, Ostrovnaya, Irina, additional, Pietzak, Eugene J., additional, Iyer, Gopa, additional, Gao, Sizhi Paul, additional, Hu, Wenhuo, additional, Al-Ahmadie, Hikmat A., additional, and Solit, David B., additional

Published
2022
Full Text
View/download PDF

37. Reply by Authors

Author

Beebe, Sarah, primary, Scimeca, Alicia, additional, Diab, Dinah, additional, Wong, Nathan C., additional, Posid, Tasha, additional, and Dason, Shawn, additional

Published
2022
Full Text
View/download PDF

44. Clinical utility of subclassifying positive surgical margins at radical prostatectomy

Author

Dason, Shawn, primary, Vertosick, Emily A., additional, Udo, Kazuma, additional, Sjoberg, Daniel D., additional, Vickers, Andrew J., additional, Al‐Ahmadie, Hikmat, additional, Chen, Ying‐Bei, additional, Gopalan, Anuradha, additional, Joseph Sirintrapun, S., additional, Tickoo, Satish K., additional, Scardino, Peter T., additional, Eastham, James A., additional, Reuter, Victor E., additional, and Fine, Samson W., additional

Published
2021
Full Text
View/download PDF

46. Reply by Authors

Author

Dason, Shawn, primary, Wong, Nathan C., additional, Donahue, Timothy F., additional, Meier, Andreas, additional, Zheng, Junting, additional, Mannelli, Lorenzo, additional, Di Paolo, Pier Luigi, additional, Dean, Lucas W., additional, McPherson, Victor A., additional, Rosenberg, Jonathan E., additional, Bajorin, Dean F., additional, Capeanu, Marinella, additional, Dalbagni, Guido, additional, Alberto Vargas, H., additional, and Bochner, Bernard H., additional

Published
2021
Full Text
View/download PDF

48. Reply by Authors

Author

Almassi, Nima, primary, Cha, Eugene K., additional, Vertosick, Emily A., additional, Huang, Chun, additional, Wong, Nathan, additional, Dason, Shawn, additional, McPherson, Victor, additional, Dean, Lucas, additional, Benfante, Nicole, additional, Sjoberg, Daniel D., additional, Rosenberg, Jonathan E., additional, Bajorin, Dean F., additional, Herr, Harry W., additional, Dalbagni, Guido, additional, and Bochner, Bernard H., additional

Published
2020
Full Text
View/download PDF

49. Trends in Management and Outcomes among Patients with Urothelial Carcinoma Undergoing Radical Cystectomy from 1995 to 2015: The Memorial Sloan Kettering Experience

Author

Almassi, Nima, primary, Cha, Eugene K., additional, Vertosick, Emily A., additional, Huang, Chun, additional, Wong, Nathan, additional, Dason, Shawn, additional, McPherson, Victor, additional, Dean, Lucas, additional, Benfante, Nicole, additional, Sjoberg, Daniel D., additional, Rosenberg, Jonathan E., additional, Bajorin, Dean F., additional, Herr, Harry W., additional, Dalbagni, Guido, additional, and Bochner, Bernard H., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results